Free Trial
NYSE:NEUE

NeueHealth (NEUE) Stock Price, News & Analysis

NeueHealth logo
$6.52 +0.04 (+0.54%)
Closing price 08/22/2025 03:16 PM Eastern
Extended Trading
$6.52 0.00 (0.00%)
As of 08/22/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About NeueHealth Stock (NYSE:NEUE)

Key Stats

Today's Range
$6.50
$6.64
50-Day Range
$6.52
$6.92
52-Week Range
$3.79
$7.66
Volume
16,967 shs
Average Volume
6,528 shs
Market Capitalization
$58.86 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00
Consensus Rating
Hold

Company Overview

NeueHealth Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
28th Percentile Overall Score

NEUE MarketRank™: 

NeueHealth scored higher than 28% of companies evaluated by MarketBeat, and ranked 810th out of 937 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    NeueHealth has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    NeueHealth has received no research coverage in the past 90 days.

  • Read more about NeueHealth's stock forecast and price target.
  • Earnings Growth

    Earnings for NeueHealth are expected to grow in the coming year, from ($9.13) to ($9.01) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of NeueHealth is -0.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of NeueHealth is -0.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about NeueHealth's valuation and earnings.
  • Percentage of Shares Shorted

    0.55% of the float of NeueHealth has been sold short.
  • Short Interest Ratio / Days to Cover

    NeueHealth has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in NeueHealth has recently increased by 142.31%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    NeueHealth does not currently pay a dividend.

  • Dividend Growth

    NeueHealth does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.55% of the float of NeueHealth has been sold short.
  • Short Interest Ratio / Days to Cover

    NeueHealth has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in NeueHealth has recently increased by 142.31%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    NeueHealth has a news sentiment score of 1.31. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.69 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for NeueHealth this week, compared to 1 article on an average week.
  • Search Interest

    1 people have searched for NEUE on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, NeueHealth insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    63.30% of the stock of NeueHealth is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    63.88% of the stock of NeueHealth is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about NeueHealth's insider trading history.
Receive NEUE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NeueHealth and its competitors with MarketBeat's FREE daily newsletter.

NEUE Stock News Headlines

A New Way to Double Your Retirement Income?
Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boom. For retirees, that could mean a way to generate reliable monthly income—without the outdated 4% withdrawal rule, risky trading, or high-fee annuities. If you’re ready to stop worrying about money running out and start enjoying the freedom to cover expenses, treat loved ones, and live life on your terms, this may be exactly what you’ve been waiting for.tc pixel
NeueHealth Reports Second Quarter 2025 Results
NeueHealth Reports Second Quarter 2025 Results
See More Headlines

NEUE Stock Analysis - Frequently Asked Questions

NeueHealth's stock was trading at $7.42 at the beginning of the year. Since then, NEUE shares have decreased by 12.1% and is now trading at $6.5250.

NeueHealth, Inc. (NYSE:NEUE) posted its earnings results on Thursday, August, 7th. The company reported ($1.68) earnings per share (EPS) for the quarter, beating the consensus estimate of ($4.77) by $3.09. The company had revenue of $209.08 million for the quarter, compared to analyst estimates of $249.50 million.
Read the conference call transcript
.

NeueHealth's top institutional investors include Skandinaviska Enskilda Banken AB publ (0.32%). Insiders that own company stock include Jay Matushak, Tomas Orozco, Jeffery Michael Craig and Jeffrey J Scherman.
View institutional ownership trends
.

Shares of NEUE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that NeueHealth investors own include Jiuzi (JZXN), ARMOUR Residential REIT (ARR), Aethlon Medical (AEMD), Aditxt (ADTX), Ainos (AIMD), Adial Pharmaceuticals (ADIL) and Avalon GloboCare (ALBT).

Company Calendar

Last Earnings
8/07/2025
Today
8/24/2025
Next Earnings (Estimated)
11/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Medical Services
Sub-Industry
Insurance
Current Symbol
NYSE:NEUE
Previous Symbol
NYSE:NEUE
CIK
1671284
Fax
N/A
Employees
1,252
Year Founded
N/A

Price Target and Rating

High Price Target
$7.00
Low Price Target
$7.00
Potential Upside/Downside
+7.3%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($15.97)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$134.68 million
Net Margins
-9.08%
Pretax Margin
-6.84%
Return on Equity
N/A
Return on Assets
-13.01%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.70
Quick Ratio
0.70

Sales & Book Value

Annual Sales
$936.66 million
Price / Sales
0.06
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($151.73) per share
Price / Book
-0.04

Miscellaneous

Outstanding Shares
9,020,000
Free Float
3,312,000
Market Cap
$58.86 million
Optionable
N/A
Beta
0.57
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NYSE:NEUE) was last updated on 8/24/2025 by MarketBeat.com Staff
From Our Partners